The company employs 65 people in its new location, and Noorian said he expects that number to nearly double within the next two years
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression
Growing shift toward long-acting, once-weekly injectable formulations to improve patient compliance
Still, major trials on two GLP-1 drugs (tirzepatide and semaglutide) offer some information about the impact of these medications on muscle loss, according to a 2025 analysis in Obesity Reviews
A new randomized, double-blind, placebo-controlled clinical study found that participants who took Calocurb for 24 weeks lost an average of 8.3 pounds (3.77 kg), compared with 0.88 pounds (0.4 kg) among those who received a placebo
When applied during the first month, they can reduce the intensity of dose-related GI symptoms and make dose holds more productive